ATLANTA—Transurethral resection of the prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH) is associated with an increased risk of complications but a significantly lower risk of repeat BPH surgery compared to minimally-invasive surgeries, according to a poster presentation at the American Urological Association 2012 annual meeting.
Sean P. Elliott, MD, of the University of Minnesota Medical School in Minneapolis, and colleagues noted that at five years, repeat BPH surgery occurred in about 20% of men after initial treatment with transurethral microwave therapy (TUMT), transurethral needle ablation (TUNA), or laser therapies.
Investigators examined 624,319 men from 2001 to 2007 who underwent BPH surgery. With a mean follow-up of 3.6 years, TURP was the most common procedure (52.3%) performed in patients. Urethral stricture was the most common complication overall (4.4%) and in patients who had underwent TURP (5.7%), but was the least common complication after TUMT (2.3%) or TUNA (2.6%).